U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240116) titled 'Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects' on Nov. 07.

Brief Summary: This single-center, randomized, open-label study will assess the relative bioavailability of 2 miricorilant (CORT118335) tablet formulations.

Study Start Date: Sept. 11

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Miricorilant Treatment A

Miricorilant 100 mg (1 x 100 mg) Kinetisol immediate release (IR) tablet for oral administration

DRUG: Miricorilant Treatment B

Miricorilant 100 mg (2 x 50 mg) Kinetisol IR tablet for oral administration

DRUG: Miricorilant Tre...